Downregulation of Osteoblast Markers and Induction of the Glial Fibrillary Acidic Protein by Oncostatin M in Osteosarcoma Cells Require PKCδ and STAT3-Reference-Cited by-同舟云学术

Downregulation of Osteoblast Markers and Induction of the Glial Fibrillary Acidic Protein by Oncostatin M in Osteosarcoma Cells Require PKCδ and STAT3

Published:2004-08-23 Issue:11 Volume:19 Page:1850-1861
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Chipoy Céline,Berreur Martine,Couillaud Séverine,Pradal Gilbert,Vallette François,Colombeix Caroline,Rédini Françoise,Heymann Dominique,Blanchard Frédéric

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference51 articles.

1. Leukemia inhibitory factor, interleukin 6, and other cytokines using the gp130 transducing receptor: Roles in inflammation and injury;Gadient;Stem Cells,1999

2. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27;Pflanz;J Immunol,2004

3. The oncostatin M signalling pathway: Reversing the neoplastic phenotype?;Grant;Mol Med Today,1999

4. Oncostatin M, a multifunctional cytokine;Tanaka;Rev Physiol Biochem Pharmacol,2003

5. gp130 cytokine family and bone cells;Heymann;Cytokine,2000

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical relevance of OSM in inflammatory diseases: a comprehensive review;Frontiers in Immunology;2023-09-29

2. The role of DNA methylation on gene expression in the vertebrae of ancestrally benzo[a]pyrene exposed F1 and F3 male medaka;Epigenetics;2023-06-15

3. Interleukin 6 promotes BMP9-induced osteoblastic differentiation through Stat3/mTORC1 in mouse embryonic fibroblasts;Aging;2023-02-01

4. The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression;Molecular Medicine Reports;2022-08-29

5. Ulipristal acetate simultaneously provokes antiproliferative and proinflammatory responses in endometrial cancer cells;Heliyon;2022-01